Novartis Ag Adr Stock Price Prediction
| NVS Stock | USD 97.53 0.33 0.34% |
Oversold Vs Overbought
35
Oversold | Overbought |
Quarterly Earnings Growth 0.846 | EPS Estimate Next Quarter 1.8 | EPS Estimate Current Year 7.5986 | EPS Estimate Next Year 8.3416 | Wall Street Target Price 112.6664 |
Using Novartis hype-based prediction, you can estimate the value of Novartis AG ADR from the perspective of Novartis response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Novartis using Novartis' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Novartis using crowd psychology based on the activity and movement of Novartis' stock price.
Novartis Short Interest
An investor who is long Novartis may also wish to track short interest. As short interest increases, investors should be becoming more worried about Novartis and may potentially protect profits, hedge Novartis with its derivative instruments, or be ready for some potential downside.
200 Day MA 106.5054 | Short Percent 0.002 | Short Ratio 3.9 | Shares Short Prior Month 4.5 M | 50 Day MA 101.449 |
Novartis AG ADR Hype to Price Pattern
Investor biases related to Novartis' public news can be used to forecast risks associated with an investment in Novartis. The trend in average sentiment can be used to explain how an investor holding Novartis can time the market purely based on public headlines and social activities around Novartis AG ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Novartis' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Novartis.
Novartis Implied Volatility | 0.38 |
Novartis' implied volatility exposes the market's sentiment of Novartis AG ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Novartis' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Novartis stock will not fluctuate a lot when Novartis' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Novartis to buy its stock at a price that has no basis in reality. In that case, they are not buying Novartis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Novartis after-hype prediction price | USD 97.72 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Novartis contract
Based on the Rule 16, the options market is currently suggesting that Novartis AG ADR will have an average daily up or down price movement of about 0.0238% per day over the life of the 2025-04-17 option contract. With Novartis trading at USD 97.53, that is roughly USD 0.0232 . If you think that the market is fully incorporating Novartis' daily price movement you should consider acquiring Novartis AG ADR options at the current volatility level of 0.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Novartis |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novartis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novartis After-Hype Price Prediction Density Analysis
As far as predicting the price of Novartis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Novartis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Novartis, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Novartis Estimiated After-Hype Price Volatility
In the context of predicting Novartis' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Novartis' historical news coverage. Novartis' after-hype downside and upside margins for the prediction period are 96.68 and 98.76, respectively. We have considered Novartis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Novartis is very steady at this time. Analysis and calculation of next after-hype price of Novartis AG ADR is based on 3 months time horizon.
Novartis Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Novartis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novartis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Novartis, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.27 | 1.04 | 0.19 | 0.23 | 9 Events / Month | 8 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
97.53 | 97.72 | 0.19 |
|
Novartis Hype Timeline
On the 19th of January Novartis AG ADR is traded for 97.53. The entity has historical hype elasticity of 0.19, and average elasticity to hype of competition of 0.23. Novartis is anticipated to increase in value after the next headline, with the price projected to jump to 97.72 or above. The average volatility of media hype impact on the company the price is about 146.48%. The price appreciation on the next news is projected to be 0.19%, whereas the daily expected return is now at -0.27%. The volatility of related hype on Novartis is about 123.81%, with the expected price after the next announcement by competition of 97.76. The company reported the last year's revenue of 46.66 B. Total Income to common stockholders was 8.57 B with profit before taxes, overhead, and interest of 37.87 B. Considering the 90-day investment horizon the next anticipated press release will be in about 9 days. Check out Novartis Basic Forecasting Models to cross-verify your projections.Novartis Related Hype Analysis
Having access to credible news sources related to Novartis' direct competition is more important than ever and may enhance your ability to predict Novartis' future price movements. Getting to know how Novartis' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Novartis may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AZN | AstraZeneca PLC ADR | (0.15) | 7 per month | 0.00 | (0.17) | 1.68 | (3.18) | 8.50 | |
| GSK | GlaxoSmithKline PLC ADR | (0.17) | 8 per month | 0.00 | (0.18) | 1.95 | (2.17) | 6.27 | |
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 0.00 | (0.12) | 1.20 | (2.28) | 5.51 | |
| BMY | Bristol Myers Squibb | (0.53) | 8 per month | 1.39 | 0.05 | 2.51 | (2.54) | 14.38 | |
| SNY | Sanofi ADR | (0.62) | 8 per month | 0.00 | (0.09) | 2.16 | (2.31) | 10.59 | |
| MRK | Merck Company | 0.04 | 8 per month | 0.00 | (0.15) | 1.74 | (2.17) | 5.17 | |
| BAYRY | Bayer AG PK | 0.00 | 0 per month | 0.00 | 0.45 | 5.90 | (1.47) | 7.99 | |
| GILD | Gilead Sciences | (1.41) | 8 per month | 1.35 | 0.08 | 1.94 | (2.23) | 10.79 | |
| JNJ | Johnson Johnson | 1.06 | 8 per month | 0.00 | (0.16) | 1.70 | (1.71) | 4.50 | |
| ABBV | AbbVie Inc | (1.68) | 8 per month | 0.00 | (0.09) | 2.37 | (1.92) | 18.93 | |
| LLY | Eli Lilly and | 13.39 | 8 per month | 0.00 | (0.18) | 3.25 | (4.21) | 11.14 | |
| PFE | Pfizer Inc | 0.15 | 7 per month | 0.00 | (0.10) | 2.03 | (2.04) | 6.72 |
Novartis Additional Predictive Modules
Most predictive techniques to examine Novartis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novartis using various technical indicators. When you analyze Novartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Novartis Predictive Indicators
The successful prediction of Novartis stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Novartis AG ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Novartis based on analysis of Novartis hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Novartis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novartis's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.0381 | 0.0344 | 0.031 | 0.0241 | Price To Sales Ratio | 3.8 | 4.52 | 5.2 | 3.86 |
Story Coverage note for Novartis
The number of cover stories for Novartis depends on current market conditions and Novartis' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novartis is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novartis' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Novartis Short Properties
Novartis' future price predictability will typically decrease when Novartis' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Novartis AG ADR often depends not only on the future outlook of the potential Novartis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novartis' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.1 B | |
| Cash And Short Term Investments | 14 B |
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.